ophthalmologytimes2h
Regeneron acquires UK-based biotech company Oxular Limited
Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October ...
ophthalmologytimes4h
Prevent Blindness Ohio offers free glaucoma resources to patients and professionals
These resources include downloadable fact sheets, glaucoma financial assistance resources, shareable social media graphics, ...
ophthalmologytimes21h
Oculis releases positive topline results from phase 2 ACUITY trial evaluating OCS-05 in acute optic neuritis
The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to ...
ophthalmologytimes23h
Oculis releases positive topline results from phase 2 ACUITY trial evaluating OSC-05 in acute optic neuritis
The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to ...